HOME >> MEDICINE >> NEWS
Top anti-arthritis drugs cause skin disease

Members of the second most important family of drugs used to treat rheumatoid arthritis can cause serious dermatological conditions in a quarter of patients under treatment, reveals a study published today in the journal Arthritis Research and Therapy.

Last year saw the withdrawal of frontline anti-arthritis drug Vioxx, which belongs to the cox-2 inhibitors family, when it was revealed that it poses a significant risk of heart attack and stroke. Similar findings were reported for other cox-2 inhibitors, although they are still on the market. This study shows that another family of anti-arthritis drugs, Tumour Necrosis Factor alpha (TNF-alpha) blocking agents, trigger skin conditions in 25% of patients undergoing treatment. TNF-alpha blocking agents are used to halt the process of joint destruction in patients with severe arthritis conditions.

In the first study of the kind Marcel Flendrie and colleagues, from Radboud University Nijmegen Medical Centre in the Netherlands, followed a population of 289 patients who had been undergoing treatment for rheumatoid arthritis with TNF-alpha blocking drugs for a period of one to ten years. The drugs the patients had been taking included two anti-TNF-alpha antibodies, infliximab and adalimumab, and the TNF-alpha receptors etanercept and lenercept.

The results of the study show that 25% of patients on therapy suffered from a dermatological condition that led them to visit a skin specialist. In a control group of patients who were not undergoing TNF-alpha blocking therapy and had less severe disease only 13% visited a dermatologist during the same period of time.

The most frequent conditions that patients on therapy suffered from were: skin infections - 33 infections were recorded; eczema, which was diagnosed 20 times; and drug eruptions, which occurred mainly at the beginning of the treatment and were important enough for 7 patients to stop therapy. In addition, 12 patients were diagnosed
'"/>

Contact: Juliette Savin
juliette@biomedcentral.com
44-207-631-9931
BioMed Central
3-Apr-2005


Page: 1 2

Related medicine news :

1. UIC researchers to develop new drugs to fight bioterrorism
2. Statin drugs may delay progressive artery damage in children
3. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
4. Experts call for urgent research into anti-epileptic drugs given to children
5. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
6. Antipsychotic drugs increase risk of death in older people with dementia
7. Antipsychotic drugs increase risk of death in older people with dementia
8. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
9. Panel offers guidelines on skin reactions to new class of cancer drugs
10. Blood-thinning drugs need closer monitoring
11. Comparison of patients access to new and better cancer drugs reveals inequalities between countries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2020)... ... March 27, 2020 , ... With social distancing, or ... by the day, people of all ages are challenged to find different ways ... interactions in the best of times—the physical distance mandated to prevent the pandemic’s ...
(Date:3/28/2020)... ... March 27, 2020 , ... To help prevent ... offering telemedicine as an alternative approach to seeing their patients. This approach will ... comfort of their own home or office using video conference and telecommunications technology, ...
(Date:3/28/2020)... , ... March 28, 2020 , ... ... management services, integrated practice management, and patient engagement solutions has expanded the availability ... , In this time of crisis, telemedicine has a big role in ...
(Date:3/27/2020)... ... March 27, 2020 , ... Justin P. Kubeck, MD ... Dr. Kubeck has been approved every year consecutively since 2016. Dr. Kubeck is ... Surgery. , Dr. Kubeck’s medical education began at Thomas Jefferson University. He ...
(Date:3/27/2020)... ... 27, 2020 , ... NeoTract, a wholly owned subsidiary of ... today announced that Harpreet Wadhwa, M.D., East Valley Urology Center in Mesa, AZ ... Dr. Wadhwa has achieved a high level of training and experience with the ...
Breaking Medicine News(10 mins):
(Date:4/2/2020)... ... ... Planning an Audit Response:, How to Handle MDSAP Findings, An FDAnews Management ... spotted by a notified body during an audit does happen. What is the best ... pressure with only 15 days to craft a response to the auditing body. , ...
(Date:4/1/2020)... ... 2020 , ... Care Station Medical Group -- In light of the rise ... to better care for our community. As New Jersey's leading urgent care and primary ... to offer medical care to patients coping with COVID-19. , "Our infectious disease ...
(Date:3/30/2020)... ... March 30, 2020 , ... CPSI ... TalkWithYourDoc.com . By leveraging technology developed by its wholly owned subsidiary, ... offering revenue-generating healthcare services while serving patients’ needs during the COVID-19 outbreak. ...
Breaking Medicine Technology:
Cached News: